Phenmetrazine CAS:134-49-6

CAS NO: 134-49-6
Phenmetrazine CAS:134-49-6
Chemical Name: 3-Methyl-2-phenylmorpholine
Molecular Formula: C11H15NO
Formula Weight: 177.24 g/mol
CAS Number: 134-49-6
Description Review
Description
Phenmetrazine is a pharmaceutical compound that has historically been utilized for its anorectic (appetite-suppressant) properties, particularly in the treatment of obesity. It acts as a central nervous system stimulant and shares structural similarities with amphetamines. This article aims to provide a thorough examination of Phenmetrazine, covering its chemical properties, similarities with other products, health implications, and much more.


Keywords and Synonyms

  • Fenmetrazin
  • Fenmetrazina
  • Phenmetrazin
  • Phenmetrazine
  • Phenmetrazinum​1​.

Similar Competitive Products

  • Phendimetrazine (Bontril, Adipost, Anorex-SR, Appecon, Melfiat, Obezine, Phendiet, Plegine, Prelu-2, Statobex)
  • Amphetamine and its various formulations
  • Ethcathinone (an active metabolite of anorectic amfepramone)
  • 3-Fluorophenmetrazine (a halogenated phenmetrazine derivative)​4​​5​​6​​7​​8​.

Health Benefits

Phenmetrazine primarily serves as an appetite suppressant, aiding in obesity treatment. It's known for producing fewer side effects like nervousness, hyperexcitability, euphoria, and insomnia compared to other stimulants, making it potentially more tolerable​9​​10​​11​.

Potential Effects

The stimulation of the central nervous system by Phenmetrazine leads to increased heart rate and blood pressure while curbing appetite. It's noted for causing less nervousness and hyperexcitability compared to drugs from the amphetamine family​12​​10​.

Product Mechanism

As a sympathomimetic drug, Phenmetrazine's mechanism resembles that of dextroamphetamine, exerting its effects through CNS stimulation. It was historically sold under the trade name Preludin for its anorectic properties​9​.

Safety and Side Effects

Common side effects may include irregular heartbeat, high blood pressure, restlessness, sleep problems, and nervousness. Serious side effects could involve severe mental changes, anxiety, and chest pain among others​12​.

Dosing Information

Phenmetrazine's dosing information might be tailored to individual needs under medical supervision, similar to other anorectic drugs. However, specific dosing guidelines for Phenmetrazine are scarce, thus consulting a healthcare professional is crucial.

Contraindications

Specific contraindications for Phenmetrazine are not readily available, but given its similarities to Phendimetrazine, caution should be exercised, especially in individuals with a history of cardiovascular issues, psychiatric disorders, or substance abuse.

Conclusion

Phenmetrazine, with its anorectic properties, offers a potential avenue for obesity treatment. However, its structural similarity to amphetamines and the associated side effects necessitate a cautious approach in its utilization. Comprehensive understanding and adherence to medical guidance are pivotal for harnessing the benefits of Phenmetrazine while mitigating risks.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code